Use of plasmapheresis and intravenous immunoglobulins in pregnant women with antiphospholipid syndrome
Our objective was to demonstrate the efficiency of therapy for antiphospholipid syndrome (APS) in pregnant women using plasmapheresis and intravenous immunoglobulins.92 women with diagnosed APS and 47 APS-free women with physiological pregnancy were under study. APS was diagnosed in accordance with...
Saved in:
Main Authors: | E. S. Orlova, S. V. Chepanov, M. S. Zainulina, S. A. Selkov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2025-01-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/2893 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
USE OF INTRAVENOUS IMMUNOGLOBULIN WITHIN THE IVF/ICSI PROTOCOL IN WOMEN WITH INFERTILITY AND ANTIPHOSPHOLIPID ANTIBODIES
by: M. I. Krivonos, et al.
Published: (2017-12-01) -
IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS
by: S. A. Sel'kov, et al.
Published: (2014-07-01) -
Determination of cytokine and growth factor levels to assess endothelial dysfunction in reproductive pathologies
by: S. V. Chepanov, et al.
Published: (2025-07-01) -
Gestation in patients with a combination of antiphospholipid and torch syndromes
by: E. N. Kravchenko, et al.
Published: (2021-07-01) -
Assessing the effectiveness of preventing placenta-associated complications in patients with burdened obstetric history and circulating antiphospholipid antibodies
by: D. R. Eremeeva, et al.
Published: (2024-09-01)